| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Ibentatug | ZB-131 | Phase 2 Clinical | Zielbio Inc | Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Cystadenocarcinoma, Serous; Ovarian Neoplasms; Solid tumours | Details |